Backflow prevention device testing definition

Backflow prevention device testing means performing functional procedures to ascertain that the device is still providing the necessary backflow protection in accordance with the Virginia Uniform Statewide Building Code.
Sample 1Sample 2Sample 3
Backflow prevention device testing means performing functional procedures to ascertain that
Sample 1
Backflow prevention device testing means performing functional procedures to ascertain
Sample 1

Examples of Backflow prevention device testing in a sentence

  • Backflow prevention device testing procedures shall be in accordance with the University of Southern California, Foundation for Cross-Connection Control and Hydraulic Research, Backflow Prevention Assembly Field Test Procedure and the manufacturer's instructions.

  • The District will notify each Customer of Record and supply the necessary forms for Backflow prevention device testing when it is time for the annual Backflow prevention test.

  • The Customer of Record shall have 30 days to comply with the Backflow prevention device testing requirements.

  • Sincerely,Marcie Saquing Executive Director 561 Kupuna Place  Hilo, HI 96720  Phone (808) 961-3747  Fax (808) 961-3740  www.HawaiiIslandAdultCare.org EMERGENCY CLOSING & TRANSPORTATION INFORMATION In the event that you cannot be here to pick up your loved one during operating hours or ANY EMERGENCY, we need to have the names of alternate authorized individuals on file.

  • Backflow prevention device testing shall be performed in accordance with applicable standards, and test results shall be provided to the Engineer.

  • Backflow prevention device testing shall be performed in accordance with the most recent edition of the Manual of Cross- Connection Control as published by the University of Southern California by a person selected from Helix Water District's “District-Approved Certified Backflow Assembly Testers” list, and test results shall be provided to the Engineer.

  • Backflow prevention device testing documentation required by District Representative, excluding devices installed on single family residential service lines.

  • Backflow prevention device testing shall be tested only by a Licensed Backflow Prevention Device Tester.

  • Their meeting(s) that takes place during the course of inspections could be considered to satisfy the requirement for an annual committee meeting if a record is kept.

  • Backflow prevention device and separation inspection and testing intervals shall not exceed 1 year.3. Backflow prevention device overhaul procedures and replacement parts shall be in accordance with the manufacturer’s recommendations.4. Backflow prevention device testing procedures shall be in accordance with the University of Southern California, Foundation for Cross-Connection Control and Hydraulic Research, Backflow Prevention Assembly Field Test Procedure and the manufacturer’s instructions.

Related to Backflow prevention device testing

  • Operational Acceptance Tests means the tests specified in the Technical Requirements and Agreed Project Plan to be carried out to ascertain whether the System, or a specified Sub system, is able to attain the functional and performance requirements specified in the Technical Requirements and Agreed Project Plan, in accordance with the provisions of GCC Clause 27.2 (Operational Acceptance Test).

  • Backflow preventer means a device or means to prevent backflow.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • technical specification means a document that prescribes technical requirements to be fulfilled by a product, process or service;

  • Phase I Clinical Trial means the initial introduction of a Licensed Product as an investigational new drug into humans as required in 21 C.F.R. § 312, designed to determine the metabolism and pharmacologic actions of the Licensed Product in humans, the side effects associated with increasing doses and, if possible, to gain early evidence on effectiveness, and also includes studies of drug metabolism, structure-activity relationships and mechanism of action in humans.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Penetration Testing means security testing in which assessors mimic real-world attacks to identify methods for circumventing the security features of an application, system, or network. (NIST SP 800-115)

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.